Skip Nav Destination

On Location

Updates from major medical meetings in the field of hematology/oncology

Understanding the Prognostic Impact of TP53 Mutations in Chronic Lymphocytic Leukemia

Lara C. Pullen, PhD

Mosunetuzumab Therapy Elicits High, Durable Responses in Patients With Follicular Lymphoma

Anna Azvolinsky, PhD

ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia

Khylia Marshall

Phase II CAPTIVATE Study: The 5.5-Year Update

Lara C. Pullen, PhD

Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results

Anna Azvolinsky, PhD

Venetoclax May Increase Toxicity But Not Efficacy When Added to R-CHOP in Double-Expressor DLBCL

Katie Robinson

Study Identifies Characteristics Related to Bispecific Antibody Response, Resistance

Leah Lawrence

Addition of Avatrombopag to Cyclosporine Can Improve Response Rate in Elderly Patients with Transfusion-Dependent, Non-Severe Aplastic Anemia

Anna Azvolinsky, PhD

Patients With Functional High-Risk Multiple Myeloma Show High Response With Ide-Cel

Lara C. Pullen, PhD

Adenine Base Editors Could Offer Alternative Approach in Beta Hemoglobinopathies Gene Therapies

Ruth Jessen Hickman, MD

Quad Regimen Reduces Risk of Progression, Death in Older Patients with NDMM

Khylia Marshall

Survival Benefit Remains Unclear for Upfront AlloHCT in Untreated Aggressive ATL

Katie Robinson

Fewer Patients With CLL/SLL Switch From Zanubrutinib to Another BTKi

Ruth Jessen Hickman, MD

Teclistamab Combination with Daratumumab, Lenalidomide Shows Promising Efficacy, Tolerability in Patients with NDMM

Anna Azvolinsky, PhD

Rituximab Maintenance in MCL Found Advantageous After Firstline Treatment With Bendamustine-Rituximab

Thomas R. Collins

Phase I Study Shows Long-Term Efficacy of GPRC5D-Directed CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

Katie Robinson

CARTITUDE-2 Cohort D: Cilta-Cel ± Len Effective for Multiple Myeloma

Lara C. Pullen, PhD

Bispecific Antibodies Potent Bridging Therapy to CAR T-Cell Therapy for R/R MM

Leah Lawrence

Machine Learning Outperforms Full Blood Count in Iron Deficiency Screening

Thomas R. Collins

Patients With Low-Grade NHL Experience High Rates of Mental Health Conditions

Ruth Jessen Hickman, MD

1 2 3 4 5

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
Mid-July 2024

Advertisement intended for health care professionals

On Location

ASH Publications

American Society of Hematology

On Location

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only